BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30139231)

  • 1. Germline Mutations and Polymorphisms of Androgen Receptor in Prostate Cancer Patients: Frequency and Results of in Silico Analysis.
    Sribudiani Y; Marwan DW; Aulanni’am A; Widodo MA; Purnomo BB; Panigoro R; Utomo AB
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2241-2245. PubMed ID: 30139231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor mutations and polymorphisms in African American prostate cancer.
    Koochekpour S; Buckles E; Shourideh M; Hu S; Chandra D; Zabaleta J; Attwood K
    Int J Biol Sci; 2014; 10(6):643-51. PubMed ID: 24948877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.
    Taplin ME; Rajeshkumar B; Halabi S; Werner CP; Woda BA; Picus J; Stadler W; Hayes DF; Kantoff PW; Vogelzang NJ; Small EJ;
    J Clin Oncol; 2003 Jul; 21(14):2673-8. PubMed ID: 12860943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short alleles of both GGN and CAG repeats at the exon-1 of the androgen receptor gene are associated to increased PSA staining and a higher Gleason score in human prostatic cancer.
    Rodríguez-González G; Cabrera S; Ramírez-Moreno R; Bilbao C; Díaz-Chico JC; Serra L; Chesa N; Cabrera JJ; Díaz-Chico BN
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):85-91. PubMed ID: 19095061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
    Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
    Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy.
    dos Santos RM; de Jesus CM; Trindade Filho JC; Trindade JC; de Camargo JL; Rainho CA; Rogatto SR
    DNA Cell Biol; 2008 Sep; 27(9):497-503. PubMed ID: 18491956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk.
    Gsur A; Preyer M; Haidinger G; Zidek T; Madersbacher S; Schatzl G; Marberger M; Vutuc C; Micksche M
    Carcinogenesis; 2002 Oct; 23(10):1647-51. PubMed ID: 12376473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer.
    Chavan SV; Maitra A; Roy N; Chavan PR
    Indian J Med Res; 2014 Mar; 139(3):371-8. PubMed ID: 24820830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?
    Mittal RD; Mishra DK; Thangaraj K; Singh R; Mandhani A
    Steroids; 2007 Apr; 72(4):335-41. PubMed ID: 17257635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.
    Misra D; Xie W; Regan MM; Ross RW; Lee GS; Germain D; Kantoff PW; Oh WK
    BJU Int; 2011 Oct; 108(7):1086-91. PubMed ID: 21410629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the AR and PSA genes as markers of susceptibility and aggressiveness in prostate cancer.
    Kuasne H; Rodrigues IS; Fuganti PE; Losi-Guembarovski R; Ito K; Kishima MO; Rodrigues MA; Rogatto SR; Santos RM; Cólus IM
    Cancer Invest; 2010 Nov; 28(9):917-24. PubMed ID: 20632874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
    Nam RK; Elhaji Y; Krahn MD; Hakimi J; Ho M; Chu W; Sweet J; Trachtenberg J; Jewett MA; Narod SA
    J Urol; 2000 Aug; 164(2):567-72. PubMed ID: 10893645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Susceptibility to Prostate Cancer: Prostate-specific Antigen and its Interaction with the Androgen Receptor (United States).
    Sieh W; Edwards KL; Fitzpatrick AL; Srinouanprachanh SL; Farin FM; Monks SA; Kronmal RA; Eaton DL
    Cancer Causes Control; 2006 Mar; 17(2):187-97. PubMed ID: 16425097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk.
    Salinas CA; Austin MA; Ostrander EO; Stanford JL
    Prostate; 2005 Sep; 65(1):58-65. PubMed ID: 15810021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
    Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
    J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.
    Binnie MC; Alexander FE; Heald C; Habib FK
    Prostate; 2005 Jun; 63(4):309-15. PubMed ID: 15599941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer.
    Alptekin D; Izmirli M; Bayazit Y; Luleyap HU; Yilmaz MB; Soyupak B; Erkoc MA; Tansug Z
    Genet Mol Res; 2012 May; 11(2):1424-32. PubMed ID: 22653589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort.
    Xue WM; Coetzee GA; Ross RK; Irvine R; Kolonel L; Henderson BE; Ingles SA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):575-9. PubMed ID: 11401905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.